WECAN (Workgroup of European Cancer Patient Advocacy Networks) presents a poster on the European Atlas on Clinical Trials in Cancer and Hematology at the WECAN Academy 2023.
EuroACT Phase 1 focuses on data gathering to identify the clinical trial landscape and the PROs which have been used in these clinical trials. In 26 disease areas, the following was collected over the last 5 years:
- Where clinical trials have been run based on WHO Europe
- Which patient-reported outcomes have been used in the clinical trials
The methodology of how the data was collected is being presented at the WECAN Academy 2023. The poster includes an overview of the project and a deep dive into Phase 1.